Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone

NCT01516424 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Blonanserin
DRUG: Risperidone

Sponsor

Sumitomo Pharma (Suzhou) Co., Ltd.